She has resigned from the former; the latter does not matter since 23andMe’s equity could be wiped out. If persistence pays off, a company that started out as little more than an intriguing idea and a ...

Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment ...

Mallinckrodt looks like it could join Purdue Pharma in reaching a settlement in its bankruptcy proceedings related to opioid litigation, after years of legal wrangling. The Ireland-headquartered ...

Her expertise is in personal finance and investing, and real estate. A stock-for-stock merger occurs when shares of one company are traded for another during an acquisition. Shareholders can trade ...

Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion. The company’s management are clearly looking to bring cheer ...

Endo + Mallinckrodt Pharmaceuticals! The ~$7B deal will "create a larger and more diversified entity with the scale and resources needed to unlock the full potential of both companies ...

Alteogen Inc. signed its first billion-dollar partnership this year for ALT-B4 technology through two separate contracts with Astrazeneca plc’s U.K.- and U.S.-based Medimmune subsidiaries worth up to ...

We are excited to share that Mallinckrodt has entered into an agreement to combine with Endo to create a global, scaled, diversified pharmaceuticals leader. This exciting combination brings ...

Novo Nordisk Drops Price of Weight-Loss Drug Wegovy for Some Patients Paying Out of Pocket ...